LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
(NASDAQ: LIVN) Delayed: 78.71 +0.21 (0.27%)
Previous Close $78.50    52 Week High $63.21 
Open $78.64    52 Week Low $41.17 
Day High $79.89    P/E N/A 
Day Low $77.74    EPS $0.00 
Volume 689,740